| Typicality: | 0.583 |
| Saliency: | 0.511 |
| for the first time | 11 | other |
| in a clinical trial | 5 | location |
| widely | 4 | degree |
| drug → be tested in → human | 84 |
| drug → be tested on → human | 46 |
| drug → be tested on → human subjects | 6 |
| drug → be tested in → human subjects | 3 |
| negative | neutral | positive |
| 0.201 | 0.615 | 0.185 |
| Raw frequency | 139 |
| Normalized frequency | 0.511 |
| Modifier score | 0.855 |
| Perplexity | 87.048 |